For the Inventor, By the Inventor

Enter assignee name

Yonkers, NY, United States of America

Aureon Laboratories, Inc.

USPTO Granted Patents = 12

% Expired Patents = 16.7

CIPO Patents = 2

Forward Citations = 287

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Olivier Saidi (9 out of 9 patents)

David Verbel (7 out of 12 patents)

Mikhail Teverovskiy (4 out of 4 patents)

4. Michael Donovan (2 out of 9 patents)

5. Angeliki Kotsianti (2 out of 2 patents)

6. Paola Capodieci (2 out of 3 patents)

7. Lian Yan (2 out of 2 patents)

8. Stefan Hamann (1 out of 2 patents)

9. Ali Tabesh (1 out of 3 patents)

10. Marina Sapir (1 out of 1 patent)

11. Faisal M Khan (1 out of 1 patent)

12. Jon Edelson (1 out of 2 patents)

13. Mark Clayton (1 out of 14 patents)

14. David A Verbel (0 patent)

12 patents: Sort by Forward Citations

1. 8093012 - Multiplex in situ immunohistochemical analysis (2012-01-10),

2. 8062897 - Diagnostic histopathology using multiplex gene expression FISH (2011-11-22),

3. 7933848 - Support vector regression for censored data (2011-04-26),

4. 7761240 - Systems and methods for automated diagnosis and grading of tissue images (2010-07-20),

5. 7702598 - Methods and systems for predicting occurrence of an event (2010-04-20),

6. 7599893 - Methods and systems for feature selection in machine learning based on feature contribution and model fitness (2009-10-06),

7. 7505948 - Support vector regression for censored data (2009-03-17),

8. 7483554 - Pathological tissue mapping (2009-01-27),

9. 7467119 - Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition (2008-12-16),

10. 7461048 - Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition (2008-12-02),

11. 7321881 - Methods and systems for predicting occurrence of an event (2008-01-22),

12. 6995020 - Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization (2006-02-07),

Aureon Laboratories, Inc. is a leading provider of advanced diagnostic solutions for cancer patients. We specialize in molecular profiling and personalized medicine, offering comprehensive testing services to healthcare providers worldwide. Our state-of-the-art laboratory facilities and expert team ensure accurate and timely results, enabling physicians to make more informed treatment decisions. Through innovative technologies and continuous research, we strive to improve patient outcomes and contribute to the advancement of cancer diagnostics and therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

12 Patents

#13 in Yonkers, NY

#1,485 in New York

#25,526 in US

#48,090 in the World

Yonkers, NY, United States of America

Aureon Laboratories, Inc.

Forward Citations = 287

13 inventors:

Olivier Saidi (9 out of 9 patents)

David Verbel (7 out of 12 patents)

Mikhail Teverovskiy (4 out of 4 patents)

4. Michael Donovan (2 out of 9 patents)

5. Angeliki Kotsianti (2 out of 2 patents)

Please report any incorrect information to [email protected]

Loading…